THC Global Group (ASX:THC)

  • Symbol:ASX:THC
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Ken Charteris
  • Founded:2016

THC Global Group (ASX:THC) Stock Price

THC Global Group (ASX:THC) Company Overview

THC Global Group Limited (ASX:THC) is a medicinal cannabis company with a vertically-integrated business model built around the "farm to pharma" ideal.

The company is focused on the development and distribution of medicinal marijuana, but also has its' hand in a number of other cannabis-relayed enterprises. This includes large-scale greenhouse design, the construction of growing facilities, and the manufacture and delivery of hydroponics materials, equipment, and nutrients.

The company already has several growing sites situated around Australia—with one located northern NSW and the other in Queensland—along with an industry-leading biopharmaceutical manufacturing facility that churns out pharma-grade medicinal products for the international market.

After manufacturing, THC's products are then distributed globally via a series of commercial partnerships with companies located in North America, Europe, and the Middle East.

The company has already been given permits by the Australian government for its' Queensland-based cultivation and R&D site—which is owned by THC's subsidiary, Canndeo—and a domestic manufacturing license allowing for product validation and study trial production was recently granted to the company, for their South Port extraction facility.

THC Global Group (ASX:THC) Financials

More From THC Global Group...

Meet The Cannabis Extraction Powerhouses – MediPharm Labs & THC Global
Aussie Cannabis Stocks Quarterly Review
Farm to Pharma – Exclusive Interview With THC Global CEO Ken Charteris
King of the Hill – THC Global Receives "Most Significant" Cannabis License in Australia
Cannabis Kingmaker: THC Global Granted Game-Changing Manufacture License
Bowling a Double – Canopy Growth Corporation Strikes Again
THC Global Secures Medicinal Marijuana Manufacturing License
Office of Drug Control Gives THC Global License to Manufacture
THC Global Halts Trading Awaiting Announcement From Office of Drug Control
Dynamic Duo – MediPharm Joins Forces with Cronos and Announces Strong Q1 Results
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.


Steven Xu
Steven Xu is a Chartered Accountant with more than 15 years’ of experience working in PricewaterhouseCoopers, and listed companies in Australia and China.

Xu has specialised in financing, IPO and M&A activities for a wide range of sectors, including technology, agriculture, smart manufacturing and healthcare. He is also the head of the MY INP Venture Capital Fund.
Ken Charteris
Chief Executive Officer
Ken Charteris has worked with multiple biotech and pharmaceutical companies over the past three decades, in a variety of roles that have ranged from CEO to Managing Director and Chairman.

Charteris has a substantial track record when it comes to the hands-on management of major international companies, and has been instrumental in the execution of THC’s strategic plan.
Jarrod White
Chief Financial Officer
Jarrod White is a Chartered Accountant and was a founding Director of Traverse Accountants Pty Ltd.

White has substantial knowledge of corporate governance and compliance, and has also been appointed Company Secretary and Chief Financial Officer of several other listed entities that operate on the Australian Stock Exchange and London Stock Exchange.

He has also acted as an advisor for a wide range of capital raisings, IPO’s and reverse takeover transactions.